Combined drug release from biodegradable bilayer coating for endovascular stents

Journal of Biomedical Materials Research. Part B, Applied Biomaterials
M GagliardiP Giusti

Abstract

In this work, the characterization of a biodegradable bilayer system, used as controlled and combined drug delivery platform, is reported. For this aim, a bilayer system, composed of poly(lactic-co-glycolic acid) and poly(3-hydroxybutyric-co-3-hydroxyvaleric acid), was investigated under physicochemical and functional aspects by evaluating polymer/polymer and polymer/stent material interactions, the kinetic of in vitro degradation, and drug release properties, comparing results with the monolayer reference systems. Obtained results showed that the bilayer system allowed increasing the total amount of eluted Tacrolimus and Paclitaxel drugs with respect to the monolayer systems in the considered testing period and conditions. This evidence was associated to a faster degradation of the tested copolymers in the bilayered configuration, excluding a synergic effect of two drugs on delivery performance. In addition, a macromolecular relaxation process was identified to govern the PLX release from poly(lactic-co-glycolic acid), whereas a pure Fickian diffusion occurred in the delivery of Tacrolimus from poly(3-hydroxybutyric-co-3-hydroxyvaleric acid).

References

Jan 1, 1996·Biomaterials·A Göpferich
Jan 10, 1998·Journal of Pharmaceutical Sciences·R T LigginsH M Burt
Jun 9, 1999·Investigational New Drugs·R J ShadeJ S Lee
Jun 6, 2000·Advanced Drug Delivery Reviews·M S Shive, J M Anderson
Feb 12, 2002·Journal of Microencapsulation·J Chen, S S Davis
Aug 27, 2002·Biomaterials·Friederike von BurkersrodaAchim Göpferich
Apr 5, 2003·The Journal of Pharmacology and Experimental Therapeutics·Shigeki TamuraShinji Yamashita
Sep 23, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jayanth PanyamVinod Labhasetwar
Oct 3, 2003·The New England Journal of Medicine·Jeffrey W MosesUNKNOWN SIRIUS Investigators
Jan 16, 2004·The New England Journal of Medicine·Gregg W StoneUNKNOWN TAXUS-IV Investigators
Mar 12, 2004·Rheumatology·D E YocumUNKNOWN Tacrolimus RA Study Group
Jul 13, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Frank AlexisFreddy Boey
Dec 18, 2004·Biomaterials·Say Chye Joachim LooYin Chiang Freddy Boey
May 5, 2005·JAMA : the Journal of the American Medical Association·Ioannis IakovouAntonio Colombo
May 17, 2005·Drugs·Monique P Curran, Caroline M Perry
Nov 23, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Xiaosong Luan, Roland Bodmeier
Jun 20, 2006·American Heart Journal·Michael S ChenDeepak L Bhatt
Dec 19, 2006·Journal of the American College of Cardiology·Matthias PfistererUNKNOWN BASKET-LATE Investigators
Feb 14, 2007·The New England Journal of Medicine·Laura MauriDonald E Cutlip
Dec 7, 2007·International Journal of Pharmaceutics·D KloseJ Siepmann
May 22, 2008·Tissue Engineering. Part a·Meghan J Cuddihy, Nicholas A Kotov
Jun 3, 2008·Biomaterials·Taiyo YoshiokaGuoping Chen

❮ Previous
Next ❯

Citations

Jun 7, 2011·International Journal of Pharmaceutics·Susanne FredenbergAnders Axelsson
Jan 3, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Nadja BegeThomas Kissel
Nov 12, 2016·Therapeutic Delivery·Mariacristina Gagliardi
Jun 27, 2020·Computer Methods in Biomechanics and Biomedical Engineering· SarifuddinPrashanta Kumar Mandal
Nov 19, 2011·The International Journal of Artificial Organs·Livia VisaiCarla Renata Arciola

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved